AlphaYouMH
Insider selling
Mark Hopman sold $102K of Beta Bionics, Inc. (BBNX) stock
Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc. (BBNX), sold 5,327 shares of BBNX stock worth $102K, per an SEC Form 4 filed Sep 3, 2026.
It was an open-market sale.
The trade happened on Sep 2, 2026, 1 day before it was made public.
BBNX has moved +13.5% since the trade date, from $19.41 to $22.04 (Sep 21, 2026 close).
- Traded
- Sep 2, 2026
- Disclosed
- Sep 3, 2026
- Filing delay
- 1 day
- Price since
- +13.5%
- Role
- Chief Commercial Officer
- Source
- SEC Form 4
More BBNX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.